Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-11-17
1997-09-09
Walsh, Stephen
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530395, 530380, A61K 3816, C07K 14705
Patent
active
056657013
ABSTRACT:
The subject invention provides a platelet membrane glycoprotein, designated F11, which serves as a receptor for the monoclonal antibody M.Ab.F11. The purified platelet membrane glycoprotein has a deglycosylated molecular weight of about 29 kD. A partial sequence for the glycoprotein is also provided, as well as expression vectors and systems for producing the glycoprotein or fragments thereof.
REFERENCES:
Kornecki et al., "Activation of Human Platelets by a Stimulatory Monoclonal Antibody," J Biol Chem 265(17):10042-10048 (Jun. 15, 1990).
Ehrlich Yigal H.
Kornecki Elizabeth H.
Saoud Christine
The Research Foundation of State University of New York
Walsh Stephen
LandOfFree
Platelet membrane glycoprotein F11 and polypeptide fragments the does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Platelet membrane glycoprotein F11 and polypeptide fragments the, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Platelet membrane glycoprotein F11 and polypeptide fragments the will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-69971